Suppr超能文献

硼酸化 2,3,4,5-四氯邻苯二甲酰亚胺及其 2,3,4,5-四氯苯甲酰胺类似物的合成、糖苷酶抑制活性及其在硼中子俘获治疗中的抗癌活性。

Borylated 2,3,4,5-Tetrachlorophthalimide and Their 2,3,4,5-Tetrachlorobenzamide Analogues: Synthesis, Their Glycosidase Inhibition and Anticancer Properties in View to Boron Neutron Capture Therapy.

机构信息

Discipline of Chemistry, University of Newcastle, Callaghan, NSW 2308, Australia.

Priority Research Centre for Drug Development, University of Newcastle, Callaghan, NSW 2308, Australia.

出版信息

Molecules. 2022 May 26;27(11):3447. doi: 10.3390/molecules27113447.

Abstract

Tetrachlorinated phthalimide analogues bearing a boron-pinacolate ester group were synthesised via two synthetic routes and evaluated in their glycosidase modulating and anticancer properties, with a view to use them in boron neutron capture therapy (BNCT), a promising radiation type for cancer, as this therapy does little damage to biological tissue. An unexpected decarbonylation/decarboxylation to five 2,3,4,5-tetrachlorobenzamides was observed and confirmed by X-ray crystallography studies, thus, giving access to a family of borylated 2,3,4,5-tetrachlorobenzamides. Biological evaluation showed the benzamide drugs to possess good to weak potencies (74.7-870 μM) in the inhibition of glycosidases, and to have good to moderate selectivity in the inhibition of a panel of 18 glycosidases. Furthermore, in the inhibition of selected glycosidases, there is a core subset of three animal glycosidases, which is always inhibited (rat intestinal maltase α-glucosidase, bovine liver β-glucosidase and β-galactosidase). This could indicate the involvement of the boron atom in the binding. These glycosidases are targeted for the management of diabetes, viral infections (via a broad-spectrum approach) and lysosomal storage disorders. Assays against cancer cell lines revealed potency in growth inhibition for three molecules, and selectivity for one of these molecules, with the growth of the normal cell line MCF10A not being affected by this compound. One of these molecules showed both potency and selectivity; thus, it is a candidate for further study in this area. This paper provides numerous novel aspects, including expedited access to borylated 2,3,4,5-tetrachlorophthalimides and to 2,3,4,5-tetrachlorobenzamides. The latter constitutes a novel family of glycosidase modulating drugs. Furthermore, a greener synthetic access to such structures is described.

摘要

合成了带有硼-联萘酯基团的四氯邻苯二甲酰亚胺类似物,通过两条合成路线进行评价,并评估其糖苷酶调节和抗癌性质,以期将其用于硼中子俘获治疗(BNCT),这是一种有前途的癌症辐射类型,因为这种治疗对生物组织几乎没有损伤。通过 X 射线晶体学研究证实,观察到并证实了出乎意料的脱羰/脱羧反应,得到了一系列硼取代的 2,3,4,5-四氯苯甲酰胺。生物评价表明,苯甲酰胺类药物在抑制糖苷酶方面具有良好到弱的活性(74.7-870μM),并且在抑制 18 种糖苷酶的组合中具有良好到中等的选择性。此外,在抑制选定的糖苷酶时,有一组三个动物糖苷酶始终被抑制(大鼠肠麦芽糖α-葡萄糖苷酶、牛肝β-葡萄糖苷酶和β-半乳糖苷酶)。这可能表明硼原子参与了结合。这些糖苷酶是针对糖尿病、病毒感染(通过广谱方法)和溶酶体贮积病的管理而靶向的。对癌细胞系的测定显示,有三种分子对生长抑制有活性,其中一种分子具有选择性,正常细胞系 MCF10A 的生长不受该化合物的影响。其中一种分子表现出既有效又有选择性;因此,它是该领域进一步研究的候选者。本文提供了许多新的方面,包括快速获得硼取代的 2,3,4,5-四氯邻苯二甲酰亚胺和 2,3,4,5-四氯苯甲酰胺。后者构成了一类新型的糖苷酶调节药物。此外,还描述了一种更环保的此类结构的合成方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2066/9182199/02446ae51c0d/molecules-27-03447-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验